Cimlanod
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02819271)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccc(S(=O)(=O)NO)o1- Mol. weight
- 177.18 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Prodrug
Sources
- ChEMBLCHEMBL4297915 ↗
Also known as
- cxl-1427
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02157506 | Phase 2 | Jun 1, 2014 | Bristol-Myers Squibb, Cardioxyl Pharmaceuticals |
| NCT02819271 | Phase 1 | Feb 1, 2014 | Bristol-Myers Squibb, Cardioxyl Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 2 | 2 | 2 | 2014 |
| Cardioxyl Pharmaceuticals | For profit | 2 | 0 | 2 | 2014 |
2 organizations
Page 1 / 1